Siga Technologies gets orders worth $13 mln for antiviral drug
23/06/2022 13:26
June 23 (Reuters) - Drugmaker SIGA Technologies SIGA.O said on Thursday it has received orders worth about $13 million for its oral antiviral drug Tpoxx, as monkeypox cases spread globally. urn:newsml:reuters.com:*:nGNX7wzZT (Reporting by Leroy Leo in Bengaluru; Editing by Amy Caren Daniel) ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))
Recent news on SIGA Technologies
See all newsBrief: Siga Secures Contract Valued At Up To $15 Million From Canadian Department Of National Defence To Purchase Tpoxx®
SIGA Technologies Q2 revenue, profit drop as contract ends
SIGA Technologies Q1 revenue falls, net loss widens
Brief: SIGA Technologies Q1 EPS USD -0.05
Brief: EMA Recommends Restricting Use Of Tecovirimat SIGA